Absence of peritumoral fibrosis or inflammatory infiltrate may be related to clinical progression of papillary thyroid microcarcinoma

International Journal of Surgical Pathology

Volumn 17, Issue 6, 2009, Pages 432-437

  Ramos, Ana Maria De Oliveira ^a,b   Sales, Alexandre De Oliveira ^b   Barbalho De Mello, Luis Eduardo ^c   Cirino De Andrade, Márcia ^a   Pinto Paiva, Fernando ^c   Ramos, Carlos Cesar Oliveira ^c   De Carvalho Formiga, Maria Célia ^b   De Formiga Ramos, Carlos Cesar ^a,b,c   De Matos, Patricia Sabino ^d   Ward, Laura Sterian ^d  

^a State Service for Ascertaining Death in the State of Rio Grande do Norte   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^c Luiz Antônio Hospital Cancer Hospital Natal   (Brazil)

^d UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Capsule; Clinical progression; Fibrosis; Histological variant; Incidence; Papillary thyroid microcarcinoma

Indexed keywords

ADULT; AGED; ARTICLE; AUTOPSY; BRAZIL; CANCER GROWTH; FEMALE; FIBROSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; INFLAMMATORY INFILTRATE; MALE; MICROSCOPY; PAPILLARY THYROID MICROCARCINOMA; PRIORITY JOURNAL; THYROID CARCINOMA; THYROID GLAND;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOPSY; BRAZIL; CARCINOMA, PAPILLARY; CHILD; DISEASE PROGRESSION; FEMALE; FIBROSIS; GOITER, NODULAR; HUMANS; INCIDENTAL FINDINGS; INFLAMMATION; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; THYROID GLAND; THYROID NEOPLASMS; YOUNG ADULT;

EID: 71049154060     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896909333749     Document Type: Article

References (22)

1. Davies L., Welch HG Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006 ; 295: 2164-2167.
2. Coeli CM, Brito AS, Barbosa FS, Ribeiro MG, Sierio AP, Vaisman M. Incidence and mortality from thyroid cancer in Brazil. Arq Bras Endocrinol Metabol. 2005 ; 49: 503-509.
3. Rastogi T., Devesa S., Mangtani P., et al. Cancer incidence rates among South Asians in four geographic regions: India, Singapore, UK and US. Int J Epidemiol. 2008 ; 37: 147-160.
4. Mitchell I., Livingston EH, Chang AY, et al. Trends in thyroid cancer demographics and surgical therapy in the United States. Surgery. 2007 ; 142: 823-828.
5. Brumini R. CÂncer no Brasil. Dados histopatol3gicos (1976-1980). In: Campanha Nacional de Combate ao Câncer. Rio de Janeiro, Brazil: Ministério da Saúde ; 1982: 1-237.
6. Registro Nacional de Patologia Tumoral. In: Diagn3stico de CÂncer. Brasil (1981-1985). Rio de Janeiro, Brazil: MinistÉrio da Saúde, Instituto Nacional de CÂncer, Programa de Oncologia ; 1991: 1-129.
7. Liga Norte Rio-Grandense Contra o Câncer. In: Registro Hospitalar de CÂncer-Relat3rio de 1997-2001. 2 nd ed. Rio Grande do Norte, Brazil: Secretaria de Estado da Saúde Pública do Rio Grande do Norte ; 2002: 1-231.
8. Kent WD, Hall SF, Isotalo PA, Houlden RL, George RL, Groome PA Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ. 2007 ; 177: 1357-1361.
9. Baudin E., Travagli JP, Ropers J., et al. Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer. 1998 ; 83: 553-559.
10. Chow SM, Law SC, Chan JK, Au SK, Yau S., Lau WH Papillary microcarcinoma of the thyroid. Prognostic significance of lymph node metastasis and multifocality. Cancer. 2003 ; 98: 31-40.
11. Pisanu A., Reccia I., Nardello O., Uccheddu A. Risk factors for nodal metastasis and recurrence among patients with papillary thyroid microcarcinoma: differences in clinical relevance between nonincidental and incidental tumors. World J Surg. 2009 ; 33: 460-468.
12. de Matos PS, Ferreira AP, Ward LS Prevalence of papillary microcarcinoma of the thyroid in Brazilian autopsy and surgical series. Endocr Pathol. 2006 ; 17: 165-174.
13. Ron E., Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res. 1995 ; 141: 259-277. 14.
14. Nagano J., Mabuchi K., Yoshimoto Y., et al. A case-control study in Hiroshima and Nagasaki examining non-radiation risk factors for thyroid cancer. J Epidemiol. 2007 ; 17: 76-85.
15. Ward LS, Morari EC, Leite JL, et al. Identifying a risk profile for thyroid cancer. Arq Bras Endocrinol Metabol. 2007 ; 51: 713-722.
16. Memon A., Varghese A., Suresh A. Benign thyroid disease and dietary factors in thyroid cancer: a case-control study in Kuwait. Br J Cancer. 2002 ; 86: 1745-1750.
17. Ron E., Kleinerman RA, Boice JD Jr, LiVolsi VA, Flannery JT, Fraumeni JF Jr. A population-based case-control study of thyroid cancer. J Natl Cancer Inst. 1987 ; 79: 1-12.
18. Knobel M., Medeiros-Neto G. Relevance of iodine intake as a reputed predisposing factor for thyroid cancer. Arq Bras Endocrinol Metabol. 2007 ; 51: 701-712. 19.
19. Camargo RY, Tomimori EK, Neves SC, et al. Thyroid and the environment: exposure to excessive nutritional iodine increases the prevalence of thyroid disorders in Sao Paulo, Brazil. Eur J Endocrinol. 2008 ; 159: 293-299.
20. Esteves RZ, Kasamatsu TS, Kunii IS, Furuzawa GK, Vieira JG, Maciel RM Development of a semi-automated method for measuring urinary iodine and its application in epidemiological studies in Brazilian schoolchildren. Arq Bras Endocrinol Metabol. 2007 ; 51: 1477-1484.
21. Chang S., Crothers C., Lai S., Lamm S. Pediatric neurobehavioral diseases in Nevada counties with respect to perchlorate in drinking water: an ecological inquiry. Birth Defects Res A Clin Mol Teratol. 2003 ; 67: 886-892.
22. Souza SL, Assump§£o LV, Ward LS Impact of previous thyroid autoimmune diseases on prognosis of patients with well-differentiated thyroid cancer. Thyroid. 2003 ; 13: 491-495.